by Truveta Research | Feb 22, 2024 | Research, Research Insights
Aortic stenosis – the narrowing of the valve between the lower left heart chamber (left ventricle) and the aorta – is commonly diagnosed with an echocardiogram and staged according to the disease progression. However, it’s a difficult condition to study across large...
by Truveta Research | Feb 7, 2024 | Research, Research Insights
We found 13.1 emergency department visits for falls on snow or ice per 10,000 emergency department visits during wintery months; with 3x higher rates happening in states with freezing temperatures during the winters compared to states with milder winters. Wrist...
by Truveta Research | Jan 11, 2024 | Research, Research Insights
There is a complex relationship between cannabis use and mental health. We studied recent time trends of the rate of cannabis-induced disorder emergency department visits and cannabis-involved emergency department visits (both defined below). Between 2019 and 2020, we...
by Truveta Research | Nov 27, 2023 | Research, Research Insights
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15%...
by Truveta Research | Nov 10, 2023 | Research, Research Insights
Adequate treatments are a crucial piece in the fight against the spread of HIV, because they can make HIV viral load undetectable in the blood and thus untransmittable. Approved by the US Food and Drug Administration (FDA) in January 2021, one of the newest treatments...
by Truveta Research | Nov 10, 2023 | Research, Research Insights
Lecanemab received accelerated FDA approval in January 2023 and full FDA approval in July 2023. A potential side effect of the drug is brain swelling and/or small hemorrhages and is most common for people with the APOE ε4 genetic variant, therefore rates of APOE e4...
